02912: Adoptive Natural Killer (NK) Cell Immunotherapy for Canine Lymphoma

Grant Status: Open

Grant Amount: $149,979
William Kisseberth, DVM, PhD; The Ohio State University
September 1, 2021 - August 31, 2023

Sponsor(s): Golden Retriever FoundationĀ®, National Beagle Club, Pembroke Welsh Corgi Club of America, United States Australian Shepherd Foundation

Breed(s): -All Dogs
Research Program Area: Oncology - Lymphoma
Donate to Support this Research Program Area

One Health: Yes

Abstract

Natural killer (NK) cells are immune cells whose function are to eliminate virus infected and cancer cells from the body. In this clinical trial investigators will test the feasibility, safety and immunologic and biologic activity of adoptive NK cell therapy combined with chemotherapy to treat dogs with lymphoma. NK cells from healthy dogs) will be isolated from their normal blood donations, expanded in the laboratory and cultured under conditions that enhance their function. These cells will then be given to dogs with lymphoma in combination with chemotherapy. Concentrations of NK cells in blood and lymph nodes and immunologic effects in treated dogs will be assessed using correlative assays. Successful completion of this trial will inform the development of future clinical trials using adoptive NK cell therapies for the treatment of lymphoma and other cancers and diseases.

Publication(s)

None at this time.

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Get Canine Health News:
Please leave this field empty
American Kennel Club Canine Health Foundation, Inc

8051 Arco Corporate Dr.
Suite 300
Raleigh, NC 27617
(888)-682-9696

Tax ID# 13-3813813

   2020 GuideStar logo

Ā© 2021 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.